cn

cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司), a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and advancing oligonucleotide therapeutics. AusperBio leverages its proprietary Med-Oligo ASO platform with targeted delivery technologies to apply antisense oligonucleotide (ASO) therapeutics across viral infections, metabolic conditions, genetic disorders, and immune diseases; its lead candidate AHB-137 is an unconjugated ASO advancing through Phase II/III trials for chronic hepatitis B. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network as a stub; the company publishes a marketing website but no public developer or API surface.

cn is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Biopharmaceutical, and Clinical-Stage.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsBiopharmaceuticalClinical-StageOligonucleotide TherapeuticsHepatitis BDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cn: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: cn
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cn.png
name: cn
description: cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司),
  a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and
  advancing oligonucleotide therapeutics. AusperBio leverages its proprietary Med-Oligo ASO platform with targeted delivery
  technologies to apply antisense oligonucleotide (ASO) therapeutics across viral infections, metabolic conditions, genetic
  disorders, and immune diseases; its lead candidate AHB-137 is an unconjugated ASO advancing through Phase II/III trials
  for chronic hepatitis B. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network
  as a stub; the company publishes a marketing website but no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/cn/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
x-enrichment: Slug "cn" is a mis-parse of the cn.ausperbio.com regional subdomain; real entity is AusperBio Therapeutics (www.ausperbio.com).
  No developer/API surface exists (marketing SPA only; cms.ausperbio.com is an internal headless CMS, not a public API). No
  OpenAPI, SDKs, MCP, webhooks, or docs to enrich. Domain-security probed; well-known paths all catch-all 200 (no real discovery
  documents).
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Clinical-Stage
- Oligonucleotide Therapeutics
- Hepatitis B
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cn-domain-security.yml
- type: Website
  url: https://www.ausperbio.com

cn

Kin Score

Security Posture 1

Cn Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)